209 related articles for article (PubMed ID: 28938459)
1. Selective Glucocorticoid Receptor Antagonist CORT125281 Activates Brown Adipose Tissue and Alters Lipid Distribution in Male Mice.
Kroon J; Koorneef LL; van den Heuvel JK; Verzijl CRC; van de Velde NM; Mol IM; Sips HCM; Hunt H; Rensen PCN; Meijer OC
Endocrinology; 2018 Jan; 159(1):535-546. PubMed ID: 28938459
[TBL] [Abstract][Full Text] [Related]
2. The selective glucocorticoid receptor antagonist CORT125281 has tissue-specific activity.
Koorneef LL; Kroon J; Viho EMG; Wahl LF; Heckmans KML; van Dorst MMAR; Hoekstra M; Houtman R; Hunt H; Meijer OC
J Endocrinol; 2020 Jul; 246(1):79-92. PubMed ID: 32369774
[TBL] [Abstract][Full Text] [Related]
3. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
[TBL] [Abstract][Full Text] [Related]
4. Effects of the glucocorticoid antagonist RU486 in spontaneously hypertensive and Sprague Dawley rats.
Soro A; Panarelli M; Holloway CD; Fraser R; Kenyon CJ
J Endocrinol Invest; 1995 Dec; 18(11):833-9. PubMed ID: 8778154
[TBL] [Abstract][Full Text] [Related]
5. RU486 did not exacerbate cytokine release in mice challenged with LPS nor in db/db mice.
Yang B; Trump RP; Shen Y; McNulty JA; Clifton LG; Stimpson SA; Lin P; Pahel GL
BMC Pharmacol; 2008 May; 8():7. PubMed ID: 18474108
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined glucocorticoid/mineralocorticoid receptor modulation (CORT118335) on energy balance, adiposity, and lipid metabolism in male rats.
Nguyen ET; Berman S; Streicher J; Estrada CM; Caldwell JL; Ghisays V; Ulrich-Lai Y; Solomon MB
Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E337-E349. PubMed ID: 31112405
[TBL] [Abstract][Full Text] [Related]
7. Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.
Takeshita Y; Watanabe S; Hattori T; Nagasawa K; Matsuura N; Takahashi K; Murohara T; Nagata K
Hypertens Res; 2015 Nov; 38(11):741-50. PubMed ID: 26155752
[TBL] [Abstract][Full Text] [Related]
8. A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet.
Mammi C; Marzolla V; Armani A; Feraco A; Antelmi A; Maslak E; Chlopicki S; Cinti F; Hunt H; Fabbri A; Caprio M
Int J Obes (Lond); 2016 Jun; 40(6):964-72. PubMed ID: 26830012
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
Peeters BW; Ruigt GS; Craighead M; Kitchener P
Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
[TBL] [Abstract][Full Text] [Related]
10. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.
Campbell JE; Fediuc S; Hawke TJ; Riddell MC
Metabolism; 2009 May; 58(5):651-60. PubMed ID: 19375588
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
12. Identification of a selective glucocorticoid receptor modulator that prevents both diet-induced obesity and inflammation.
van den Heuvel JK; Boon MR; van Hengel I; Peschier-van der Put E; van Beek L; van Harmelen V; van Dijk KW; Pereira AM; Hunt H; Belanoff JK; Rensen PC; Meijer OC
Br J Pharmacol; 2016 Jun; 173(11):1793-804. PubMed ID: 26990179
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis.
Breivik T; Gundersen Y; Gjermo P; Opstad PK
J Periodontal Res; 2014 Feb; 49(1):36-44. PubMed ID: 23586673
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.
Nagasawa K; Matsuura N; Takeshita Y; Ito S; Sano Y; Yamada Y; Uchinaka A; Murohara T; Nagata K
Nutr Diabetes; 2016 Apr; 6(4):e207. PubMed ID: 27110688
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid Antagonism Reduces Insulin Resistance and Associated Lipid Abnormalities in High-Fructose-Fed Mice.
Priyadarshini E; Anuradha CV
Can J Diabetes; 2017 Feb; 41(1):41-51. PubMed ID: 27614803
[TBL] [Abstract][Full Text] [Related]
16. The steroid RU486 induces UCP1 expression in brown adipocytes.
Rodríguez AM; Palou A
Pflugers Arch; 2004 Nov; 449(2):170-4. PubMed ID: 15338309
[TBL] [Abstract][Full Text] [Related]
17. Mif deficiency promotes adiposity in fructose-fed mice.
Gligorovska L; Bursać B; Kovačević S; Veličković N; Matić G; Djordjevic A
J Endocrinol; 2019 Feb; 240(2):133-145. PubMed ID: 30400058
[TBL] [Abstract][Full Text] [Related]
18. The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
Fukuda-Tsuru S; Kakimoto T; Utsumi H; Kiuchi S; Ishii S
Eur J Pharmacol; 2014 Jan; 723():207-15. PubMed ID: 24309217
[TBL] [Abstract][Full Text] [Related]
19. N-stearoyltyrosine dipotassium ameliorates high-fat diet-induced obesity in C57BL/6 mice.
Tang SQ; Yin S; Liu S; Le KJ; Yang RL; Liu JH; Wang XL; Zheng ZX; Zheng L; Lin Q; Lu Y
Eur J Pharm Sci; 2015 Jul; 74():18-26. PubMed ID: 25845630
[TBL] [Abstract][Full Text] [Related]
20. A physiological glucocorticoid rhythm is an important regulator of brown adipose tissue function.
Kroon J; Schilperoort M; In Het Panhuis W; van den Berg R; van Doeselaar L; Verzijl CRC; van Trigt N; Mol IM; Sips HHCM; van den Heuvel JK; Koorneef LL; van der Sluis RJ; Fenzl A; Kiefer FW; Vettorazzi S; Tuckermann JP; Biermasz NR; Meijer OC; Rensen PCN; Kooijman S
Mol Metab; 2021 May; 47():101179. PubMed ID: 33548499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
